Ad (1904) for Ergoapiol, treatment for painful or
missing menstrual periods or other
irregularities of the menstrual cycle - or
for abortion
Read Malcolm Gladwell's riveting New
Yorker magazine article
about the invention of the birth control
pill.
See other early Pills from the National Museum
of American History.
|
MUSEUM OF MENSTRUATION AND WOMEN'S
HEALTH
Enovid brochure for
early oral birth control Pill (Physicians'
Product Brochure No. 67)
From G.D. Searle & Co., 1960
Enovid brand of norethynodrel, with
ethynylestradiol 3-methyl ether
"For Disturbances of Menstruation and
Pregnancy and for Ovulation Control"
"For the medical profession only"
Family planning, premenstrual tension (PMS),
infertility
Read
this account for medical
people of the background and
uses of this birth con-, er,
it really does not speak of
this except as "control of
ovulation."
But
see
and read more about
Enovid - The Pill -, a
steroid that changed
society.
A woman who has donated other
items to MUM kindly donated this
brochure to the museum.
Thanks!
|
Below:
Back & front covers
|
 |
 |
NEXT |
Back &
front covers - inside front
cover & title page (1) -
contents, 3
- 4-5:
Amenorrhea, primary or secondary -
6-7:
Metrorrhagia (functional
bleeding), menorrhagia (prolonged
or excessive bleeding),
hypomenorrhea - 8-9:
endocrine sterility, abortion - 10-11:
Idiopathic sterility - 12-13:
Ovulation control - 14-15 - 16-17:
Endometriosis - 18-19:
Premenstrual tension (PMS),
dysmenorrhea, side effects - 20-21:
Special notes: "There are no
known true contraindications to
Enovid," chemistry - 22-23:
Human pharmacology, action on the
endometrium - 24-25:
Action on gonadotropin excretion,
testes, vaginal desquamation.
Animal pharmacology: uterine
effects, anterior pituitary gland
effects -
26-27: Fertility studies,
other effects. Toxicity studies:
acute, subacute - 28-29:
Chronic toxicity. How supplied - 30-31:
References - 34 &
inside back cover
|
© 2009 Harry Finley. It is illegal to
reproduce or distribute any of the work on
this Web site
in any manner or medium without written
permission of the author. Please report
suspected
violations to hfinley@mum.org\
|